Ashish Bhatia, MD
Procedural Dermatology · Itasca, ILNPI 1073595690
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 16.4%. 2025 is the largest year on record at $136,598, 2.8 times the $48,003 reported in 2019.
Across 732 payments — averaging $593.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arcutis Biotherapeutics, Inc.$71K
- Mimedx Group, Inc.$54K
- Strata Skin Sciences, Inc.$53K
- Pfizer$41K
- VYNE Pharmaceuticals Inc.$40K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$29K
- plus $146K from 37 others
Across 51 payments — averaging $6312.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo Pharmaceuticals Inc.$244K
- Eli Lilly$61K
- Regeneron$16K
What the payments were for
- Consulting fees$238,57255%
- Speaking & faculty fees$131,59530%
- Grants$14,5173%
- Travel & lodging$27,0066%
- Food & beverage$22,5415%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZORYVE$63,828
- XTRAC$52,875
- CIBINQO$38,491
- AMZEEQ$25,097
- LIBTAYO$18,913
- ALTRENO$17,185
- ZILXI$14,028
- RhodoLED XL$13,699
- SILIQ$10,799
- BOVINE COLLAGEN$9,375
- XEOMIN$9,304
- DUOBRII$8,920
- LEVULAN KERASTICK$8,788
- THERMAGE FLX$7,240
- Clear & Brilliant$7,240
- ILUMYA$6,800
- QBREXZA$6,031
- BRYHALI$5,672
- DAXXIFY$5,320
- ARAZLO$2,800
How this compares
Too few procedural dermatology providers in Illinoisto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 293 | $3,964 |
| Mupirocin | 138 | $1,004 |
| Cephalexin | 53 | $312 |
| Cefadroxil | 24 | $120 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Itasca
- Keith KozenyBuffalo Grove$178K
- Scott GlazerBuffalo Grove$38K
- Michael FretzinBuffalo Grove$22K
- Amy BrodskyRockford$21K
- David OthmanChicago$5K
- Kent TaulbeeBloomington$544
- Valeria FugaliChicago$456
- Charles ZugermanChicago$420
- David FretzinPark Ridge$207
- Raymond VahlWorth$136
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.